Mast cells, the central effector cells involved in the allergic response, release histamine, arachidonic acid, and proinflammatory cytokines. We investigated the effect of the ethyl acetate fraction (EA), derived from Korean rice wine lees, on RBL-2H3 cell degranulation and passive cutaneous anaphylaxis in an animal model. The EA fraction suppressed the release of beta-hexosaminidase, a marker of degranulation, and the mRNA expression of interleukin-3 (IL-3) and IL-13. EA also successfully suppressed the passive cutaneous anaphylaxis (PCA) reaction in mice in a dose-dependent manner. These results suggest that EA can inhibit mast cell degranulation through the inhibition of IL-3 and IL-13 mRNA expression, and that EA may potentially serve as an anti-allergic agent.
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Introduction
Korean rice wine, a traditional Korean alcoholic rice-source beverage, is fermented with yeast, nuruk, a wheat-based source of the enzyme amylase. Lees, a Korean rice wine byproduct, are obtained during fermentation. The Korean rice wine lees are traditionally known to have a whitening effect on the skin as well as being a skin anti-wrinkle agent [10] . In this paper, we aimed to clarify the anti-allergic effect of Korean rice wine lees, especially the ethyl acetate (EA) fraction, in Type 1 hypersensitivity in vitro using mast cells and in passive cutaneous anaphylaxis (PCA) in mice in vivo.
Mast cells are central to the pathogenesis of immediate hypersensitivity and they are located in blood vessels and at epithelial surfaces such as the lung and intestine. It is this epithelial location that makes mast cells one of the first activators of the inflammatory response [13, 17, 19] . Mast cells have a high affinity for immune globulin E (IgE). They have a specific IgE receptor, FcεR1, on their surface. As the IgE-multivalent allergen complex binds to FcεR1, the mast cells become activated and release a range of preformed, newly synthesized mediators and cytokines that trigger potent allergic reactions [2] . In normal conditions, the mast cells have pre-formed mediators such as histamine serine proteases and β-hexosaminidase in their cytoplasmic granules. The activated mast cells release these mediators in response to immune allergic reactions through IgE-FcεR1 binding [2, 8, 12, 13, 17, 19, 20] .
β-hexosaminidase, a granule-associated exoglycosidase, has been used to monitor mast cell degranulation just as histamine has been used. β-hexosaminidase could act with tryptases and chymases to induce degradation of the extracellular matrix. This extracellular matrix degradation is an important event during the remodeling of inflamed tissue [3] .
The RBL-2H3 rat mast cell line exhibits homology with human mast cells, even though they are from rat basophilic leukemia tissue. For this reason, we assessed the level of degranulation and the interleukin-3 (IL-3) and interleukin-13 (IL-13) mRNA expression patterns using the RBL-2H3 cell line.
IL-3, one of the cytokines released by activated mast cells, acts as a multipotent hematopoietic growth factor inducing the mast cell to proliferate and encourage cell survival [16, 24] . Cytokine, IL-13, plays an important role in encouraging epithelial cell proliferation and injury repair in airway epithelial cells. 
Material and Methods

Materials
Results
EA inhibits β-hexosaminidase release in IgE-sensitized RBL-2H3 cells
The RBL-2H3 cells were activated when the IgE-antigen complex bound their receptor, FcεR1. The aggregation of Fcε R1 by the allergen-IgE complex induced mast cell degranulation and the release of mediators and cytokines [7, 9, 18, 22] . β-hexosaminidase, one of these mediators, is a marker of mast cell degranulation [16] . To determine the anti-degranulation effect of EA, we measured the level of β -hexosaminidase release in IgE-sensitized RBL-2H3 cells. We pretreated the RBL-2H3 cells with different concentrations of EA (0-300 μg/ml) for 30 min, followed by activation with DNP-BSA (50 ng/ml) for 15 min. The EA significantly inhibited DNP-BSA-induced mast cell degranulation (Fig. 1) .
To confirm that the degranulation inhibition was indeed due to the activity of EA and not cytotoxicity, we assessed EA cytotoxicity in the RBL-2H3 cells using an Ez-cytox assay. We pretreated the mast cells overnight with different doses of EA. After 24 hr, cells were treated with the Ez-cytox solution for 5 min, and the absorbance of the cell culture plate was measured with a microplate reader. EA was not cytotoxic in the RBL-2H3 cell line at concentrations up to 300 μg/ml (data not shown). These findings indicate that the reduction in degranulation of the activated RBL-2H3 cells was a result of the properties of the EA, and not cytotoxicity.
EA inhibits IL-3 and IL-13 mRNA expression levels in IgE-sensitized RBL-2H3 cells IL-3 is a multipotent hematopoietic growth factor that acts on mast cells to induce cell proliferation and encourage cell survival [16, 24] . IL-13 plays an important role in epithelial cell proliferation and injury repair in asthmatic airway epithelial cells. IL-13 also activates the cleavage of the matrix metalloproteinase 7-mediated FAS ligand in bronchial epithelial cells [21, 23] . To investigate the level of these cytokines involved in type I allergies mediated by mast cells, we examined IL-3 and IL-13 mRNA expression levels. We treated the RBL-2H3 cells with IgE (200 ng/ml) for 24 hr followed by treatment with EA at different concentrations (0-300 μg/ml). The cells were then activated with DNP-BSA (25 ng/ml) for 1 hr. We found that EA diminished the mRNA expression levels of IL-3 and IL-13 in a dose-dependent manner (Fig.  2) . From these findings, we inferred that the anti-allergic effects of EA stem from suppression of the mRNA expression of these cytokines.
EA reduces anaphylactic shock in an in vivo mouse model
We examined the effect of EA in an in vivo allergic mouse model [15] . We induced anaphylaxis by injecting IgE intradermally into one ear of each mouse. One day after IgE administration, we injected a DNP-BSA-Evans blue mixture into tail veins of each mouse to induce a systemic allergic reaction. The IgE-sensitized mouse ears subsequently swelled and turned blue. However, in the mice that received EA orally, the intensity of the blue dye decreased with increasing EA concentration. EA also appeared to suppress anaphylaxis in the mice as evidenced by the results depicted in the bar graph in Fig. 3B . These findings confirm the ability of EA to inhibit passive cutaneous anaphylaxis in an in vivo animal model just the same as in in vitro experiments (Fig.   3 ).
Discussion
Korean rice wine lees are a byproduct of Korean rice wine production. Recently, several research groups in Japan have begun to study the pharmacological benefits of Sake byproducts. They have found that Sake byproducts not only alleviate some of the symptoms of diabetes mellitus and osteoporosis, but also prevent some of the effects of arteriosclerosis [1, 10] . There are few studies of the potential health benefits of Korean rice wine lees. In this study, we investigated the effects of the ethyl acetate fraction of Korean rice wine lees on type 1 hypersensitivity mediated by mast cells.
β-hexosaminidase, a granule-associated enzyme, can be released by mast cells when the crosslinking of FcεR1 with allergen-specific IgE leads to mast cell activation [14, 15] . The β-hexosaminidase assay is an expedient method for monitoring the capacity of novel drugs to block mast cell activation and degranulation [3] . Using this method, we confirmed that EA inhibits degranulation in allergen-activated RBL-2H3 cells (Fig. 1) .
Activated mast cells deliver allergic signals to other inflammatory cells including macrophages, T cells and B cells by releasing many mediators and cytokines via degranulation and other processes. One of these cytokines, IL-3, acts on the mast cells as a multipotent hematopoietic growth factor inducing cell proliferation and encouraging cell survival [16, 24] . The another cytokine, IL-13 has an important role in the epithelial cell proliferation and injury repair in asthmatic airway epithelial cells. IL-13 activates the cleavage of the matrix metalloproteinase 7-mediated FAS ligand in bronchial epithelial cells [21, 23] . EA significantly inhibited both IL-3 and IL-13 mRNA expression (Fig. 2) . We suspect that the anti-allergic effects of EA originate from its inhibition of IL-3 and IL-13 mRNA expression. Next, we investigated how EA limits IgE-mediated passive cutaneous anaphylaxis (PCA) in mice. PCA is a well-established mast cell-dependent experiment model system for evaluating the localized IgE-mediated immediate allergic response in vivo [4, 5, 6, 11] . Consistent with the in vitro observations, EA successfully reduced allergic inflammatory reactions in the PCA-induced mice (Fig. 3) . We confirmed that EA also alleviated type 1 hypersensitivity in mice with allergic reactions induced by DNP-BSA. We do not know which pathway is blocked by EA. In further studies, we plan to determine the proteins involved in the signaling pathway interrupted by EA.
In conclusion, the ethyl acetate fraction of Korean rice wine lees suppressed mast cell degranulation. EA also suppressed the expression of IL-3 and IL-13 mRNA in antigen-stimulated RBL-2H3 cells. However, EA also suppressed passive cutaneous anaphylaxis in a mouse model. Therefore, EA could be a useful candidate for anti-allergic drugs and may have fewer side effects than current allergy medications because of its natural origin.
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